Follow‐Up and Comparative Assessment of SARS‐CoV‐2 IgA, IgG, Neutralizing, and Total Antibody Responses After BNT162b2 or mRNA‐1273 Heterologous Booster Vaccination

<h3>Background</h3><p dir="ltr">Priming with ChAdOx1 followed by heterologous boosting is considered in several countries. Nevertheless, analyses comparing the immunogenicity of heterologous booster to homologous primary vaccination regimens and natural infection are lack...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Salma Younes (6424865) (author)
مؤلفون آخرون:	Eleonora Nicolai (496034) (author), Massimo Pieri (5023022) (author), Sergio Bernardini (504056) (author), Hanin I. Daas (21841853) (author), Duaa W. Al‐Sadeq (21841856) (author), Nadin Younes (4863280) (author), Farah M. Shurrab (21841859) (author), Parveen B. Nizamuddin (21841862) (author), Fathima Humaira (21841865) (author), Nader Al‐Dewik (14777014) (author), Hadi M. Yassine (21841868) (author), Laith J. Abu‐Raddad (21841871) (author), Ahmed Ismail (2671822) (author), Gheyath K. Nasrallah (21841874) (author)
منشور في:	2024
الموضوعات:	Biological sciences Genetics Biomedical and clinical sciences Clinical sciences Immunology Health sciences Epidemiology Public health antibodies anti- S1-IgA anti- S-RBD IgG booster COVID-19 immune response neutralizing antibody vaccination
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

Follow‐Up and Comparative Assessment of SARS‐CoV‐2 IgA, IgG, Neutralizing, and Total Antibody Responses After BNT162b2 or mRNA‐1273 Heterologous Booster Vaccination

مواد مشابهة